The global digital pathology solutions for oncology market is expanding due to the rising global cancer burden, with an estimated 19.3 million new cases and 10 million deaths in 2020. The demand for digital pathology is driven by the need for faster, more accurate cancer diagnoses and the integration of AI technologies for tumor detection. Digital pathology also supports telepathology, addressing the shortage of pathologists in certain regions. These advancements are transforming oncology diagnostics and research, enhancing efficiency and accuracy in cancer care.
